Presence of immune infiltrates in early phases of prostate cancer: Establishment of a preclinical efficacy model to promote immunotherapy development

An abstract of a study by Suominen et al aiming to reveal if there is role between the immune system and development of prostate cancer, and secondly, to validate a model to be utilized later in immunotherapy development is presented. Hormonal treatment caused an increase in estradiol to testosteron...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2016-12, Vol.69, p.S56-S56
Main Authors: Suominen, M.I, Konkol, Y, Halleen, J.M, Bernoulli, J
Format: Article
Language:English
Subjects:
17β-Estradiol
Cancer
Cancer therapies
Hematology, Oncology and Palliative Medicine
Immune system
Immunotherapy
Prostate cancer
Sex hormones
Testosterone
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An abstract of a study by Suominen et al aiming to reveal if there is role between the immune system and development of prostate cancer, and secondly, to validate a model to be utilized later in immunotherapy development is presented. Hormonal treatment caused an increase in estradiol to testosterone ratio, and the prostates were enlarged.
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)32754-X